Strs Ohio Deciphera Pharmaceuticals, Inc. Transaction History

Strs Ohio

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$13.58 - $17.36 $1,358 - $1,736	-100 Reduced 6.67%	1,400 $22,000
Q3 2023 Oct 26, 2023	BUY	$12.46 - $15.48 $18,690 - $23,220	1,500 New	1,500 $19,000
Q2 2022 Jul 25, 2022	SELL	$9.11 - $13.98 $341,625 - $524,250	-37,500 Reduced 43.96%	47,800 $628,000
Q4 2021 Jan 24, 2022	BUY	$7.7 - $37.13 $612,150 - $2.95 Million	79,500 Added 1370.69%	85,300 $833,000
Q3 2021 Oct 22, 2021	BUY	$26.46 - $37.15 $150,822 - $211,755	5,700 Added 5700.0%	5,800 $197,000
Q3 2020 Dec 14, 2020	SELL	$43.8 - $58.16 $420,480 - $558,336	-9,600 Reduced 98.97%	100 $5,000
Q2 2020 Jul 23, 2020	SELL	$37.05 - $65.03 $114,854 - $201,593	-3,100 Reduced 24.22%	9,700 $579,000
Q4 2019 Jan 24, 2020	SELL	$31.7 - $69.93 $206,050 - $454,545	-6,500 Reduced 33.68%	12,800 $796,000
Q3 2019 Oct 21, 2019	BUY	$19.95 - $38.85 $173,565 - $337,995	8,700 Added 82.08%	19,300 $655,000
Q2 2019 Jul 25, 2019	SELL	$21.05 - $26.21 $159,980 - $199,196	-7,600 Reduced 41.76%	10,600 $239,000
Q3 2018 Oct 19, 2018	BUY	$33.57 - $42.1 $530,406 - $665,180	15,800 Added 658.33%	18,200 $704,000
Q4 2017 Jan 23, 2018	BUY	$16.54 - $24.2 $39,696 - $58,080	2,400	2,400 $54,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.